Shares of PB Fintech, the parent company of Policybazaar, saw a decline of 8 per cent recently after the company announced a Rs 696 crore investment in its newly formed healthcare subsidiary. The investment, planned for FY 2025-26, will be directed into PB Healthcare Services, a wholly owned subsidiary, through the purchase of equity shares and compulsory convertible preference shares (CCPS).
Investment Details and Purpose
The investment is subject to shareholder approval via postal ballot and will be made alongside contributions from external investors. CNBC reports that the funds will be used to support operational costs, enhance brand presence, and drive strategic initiatives for the subsidiary, which was incorporated in January 2025 and operates in the healthcare and allied services sector.
Equity Stake and Valuation
According to CNBC, PB Fintech will hold up to 33.63 per cent of PB Healthcare’s equity on a fully diluted basis once the transaction is completed. The investment is categorised as a related party transaction, and its valuation will be determined by a Registered Valuer.
Total Investment and Ownership
Additionally, a group of senior executives from PB Fintech will also acquire stakes in PB Healthcare, bringing the total investment to Rs 828.75 crore, representing a 40.04 per cent stake and valuing the subsidiary at Rs 2,100 crore.
Health Insurance Business Growth
CNBC highlights that PB Fintech’s health insurance business is currently growing at four times the industry average, positioning it as a key driver of long-term value. Health insurance contributes to over 60 per cent of PB Fintech’s net present value (NPV) and accounts for more than 30 per cent of its total premium collections.
Stock Performance
Following the investment news, shares of PB Fintech were trading 6.7 per cent lower on Wednesday at Rs 1,371.2, marking a 39 per cent drop from its peak of Rs 2,246. The stock opened at an intraday high of Rs 1,450.70 on the BSE but later dropped to Rs 1,389.60.
